Market Size of Global Anal Fistula Treatment Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 3.80 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Anal Fistula Treatment Market Analysis
The anal fistula treatment market is expected to register a CAGR of 3.8% over the forecast period.
COVID-19 had a significant impact on the anal fistula treatment market. For instance, as per the article published in 2021 under the title 'Insights into the management of anorectal disease in the coronavirus 2019 disease era', during the COVID-19 pandemic, there was a delay in the treatment of anal fistula, which caused an uncomfortable situation for patients. In such cases, outpatient exploration with proctoscopy, and seton placement, were alternative options based on a previous study in Crohn's disease patients. Furthermore, as per the blog published in 2021 under the title 'Anal Fissure Cases On The Rise In Covid Era; Treatment is Must!', other than antibiotics, patients overdosing on vitamin, zinc tablets and herbal tonics exacerbated the symptoms of an existing fissure in the long run. Patients with no history of anal fissures also show symptoms of the condition due to these medications during COVID-19. According to the same source, the occurrence of anal fissures had been reported in patients who had previously received COVID-19 treatment. Hence, considering the above-mentioned factors, COVID-19 had a notable impact on the anal fistula treatment market.
The anal fistula treatment market is anticipated to show rapid growth due to the rising cases of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, the launch of new products, and growing demand for non-surgical methods such as fibrin glue injection, adipose-derived stem cells therapy. For instance, the research, which was carried out by scientists at the University of Nottingham and funded by Crohn's & Colitis UK and Coeliac UK in 2022 showed that the prevalence of Crohn's and Colitis in the United Kingdom (UK) population is far higher than previously thought. The same study reported that 1 in every 123 people in the UK have either Crohn's disease or ulcerative colitis. This amounts to a total of nearly half a million people in the UK living with inflammatory bowel disease (IBD). Therefore, although inflammatory bowel disease is not that common, it still impacts a significant amount of people in the UK.
In addition, there is a rise in demand for safe and effective treatment with no chance of recurrence and fewer side effects which is propelling the key industry players to introduce advanced drugs and devices. Additionally, the technological advancement in anal fistula treatment is boosting market growth. For instance, as per the article published in 2021 under the title 'Advances in the Treatment of Anal Fistula: A Mini-Review of Recent Five-Year Clinical Studies', several combined drainage Seton procedures (pulling Seton, electric-acoustic stimulation (EAS)-sparing Seton after rerouting, and rerouting Seton around the EAS combined with mucosal advancement flap) and LIFT-plug are considered viable therapy for complex anal fistulas. Such advancements in the field of anal fistula treatment are anticipated to boost market growth.
Hence, as per the factors mentioned above, the anal fistula treatment market is likely to witness growth over the forecast period. However, the high cost associated with the anal fistula treatment and lack of awareness regarding the anal fistula treatment restrain the market growth.
